Serum insulin-like growth factor-1 predicts disease progression and survival in patients with hepatocellular carcinoma who undergo transarterial chemoembolization.

PLoS One · 2014 · PMC3942491 · PMID 24595361

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

showed a trendP = 0.01actually significant

Additionally, the levels of IGF-1 showed a trend toward a decrease with advancingtumor stage, determined by the American Joint Committee on Cancer (AJCC) tumor-node-metastasis (TNM) staging ( ρ = −0.218, P = 0.01) and Okuda ( ρ = −0.273, P = 0.001).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.